This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Zimmer Highlights Vivacit-E® Vitamin E Advanced Bearing Technology At 2013 AAOS Annual Meeting

Stocks in this article: ZMH

CHICAGO, March 21, 2013 /PRNewswire/ -- Zimmer Holdings, Inc. (NYSE: ZMH; SIX: ZMH), a global leader in musculoskeletal health, is highlighting Vivacit-E® Advanced Bearing Technology with Vitamin E at the 2013 American Academy of Orthopaedic Surgeons annual meeting.  Vivacit-E material is formulated with antioxidant protection to deliver the longest lasting bearing material for orthopaedic implants. Zimmer's proprietary manufacturing process results in an advanced highly cross-linked polyethylene material that delivers unmatched oxidative stability, ultra-low wear rates and exceptional strength.  Zimmer first introduced Vivacit-E technology in hip replacements, and the material is now also available in unicompartmental knee replacements and Persona TM The Personalized Knee System

It is widely understood in orthopaedics that oxidation is a primary cause of articular surface decay, which can increase wear leading to osteolysis and implant failure.  The Vitamin E incorporated in Vivacit-E material is a powerful antioxidant that quenches harmful free radicals to prevent oxidative material degradation.   Vivacit-E technology prevents oxidative aging through an advanced grafting process that covalently binds the Vitamin E into the polymer chain.  

" Vivacit-E technology is the next great material science innovation from Zimmer.  This advanced bearing material is engineered with antioxidant protection for exceptional wear resistance and long-term oxidative stability," said Jeff McCaulley, President of Zimmer Reconstructive.  "With exciting applications already in hips and knees, Vivacit-E material will become a platform technology across Zimmer's portfolio of products, much like our Trabecular Metal TM Technology."

In comparative in-vitro wear tests, after 50 million cycles, Vivacit-E hip replacement liners demonstrated a 95% reduction in wear when compared to conventional polyethylene liners tested to 5 million cycles.  In knee replacements, Vivacit-E material demonstrated a 96% reduction in wear compared to conventional polyethylene when tested to 5 million cycles.  Extensive testing demonstrated Vivacit-E technology also retains its improved tensile strength and does not elute Vitamin E, unlike first generation Vitamin E materials.  After accelerated aging to 16 times longer than the industry standard, Vivacit-E material maintained its physical properties and oxidative stability.

For more information about Vivacit-E Vitamin E Advanced Bearing Technology, visit Zimmer at Booth 529 at the 2013 American Academy of Orthopaedic Surgeons annual meeting in Chicago, or go to www.zimmer.com.

About the CompanyFounded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products.  Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries.  Zimmer's 2012 sales were approximately $4.5 billion.  The Company is supported by the efforts of more than 8,500 employees worldwide.

Zimmer Safe Harbor StatementThis press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management.  Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology.  These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially.  For a list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission.  We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports.  Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate.  This cautionary statement is applicable to all forward-looking statements contained in this document.

SOURCE Zimmer Holdings, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 18,053.71 +23.50 0.13%
S&P 500 2,088.77 +6.89 0.33%
NASDAQ 4,806.8590 +33.3870 0.70%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs